Salicin itself could not cure illness. It had to be broken down and converted into Salicylic Acid by intestinal flora within the human body before it became effective.
But if Salicylic Acid compounds were taken directly, the drug's utilization rate would increase substantially.
Thus, Joseph had ordered the pharmaceutical factory to conduct extensive experiments in producing Salicylic Acid several years ago. However, it was not until the beginning of this year that a scholar named Antoine de Fourcroy successfully converted Salicin into Salicylic Acid through oxidation.
Tests by the pharmaceutical factory showed that Sodium Salicylate was three to five times more effective than Salicin!
It was easy to imagine that once this medicine entered production, it would surely bring enormous profits to the pharmaceutical factory.
The cheaply sold "Crown Prince's Blessing" had already generated profits of more than 300,000 Francs every year. The Enhanced Blessing was priced at 2 Francs per tablet for external sale; if sales volume remained unchanged, profits would rise to more than 1.5 million Francs.
And generally speaking, a more effective medicine would certainly sell far better than an old product.
At the same time, the Enhanced Blessing would be an excellent advertisement for French medicine—Crown Prince's Blessing and Glucose had already made the Paris Pharmaceutical Factory renowned throughout Europe, and the enhanced version would undoubtedly further strengthen the brand's image.
As a result, established medicines such as Cinchona, Marigold Tincture, Analgesics, and Colchicum Tincture produced by the Paris Pharmaceutical Factory would also become more popular.
Joseph estimated that, once the large-scale double-blind experiments on medicines currently underway at the Medical and Health Bureau were completed, some herbs proven effective would also be added to the product list.
By then, the French pharmaceutical industry's market would also be worth tens of millions of Francs.
Of course,